Sun Caiyu について
Shandong Provincial Key Laboratory of Infection and Immunology, Department of Immunology, School of Basic Medical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, 250012, Shandong, China について
Sun Caiyu について
Shandong Provincial Clinical Research Center for Immune Diseases and Gout, Jinan, 250012, China について
Jing Weiqiang について
Department of Urology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, 250012, Shandong, China について
Xiong Gaozhong について
Shandong Provincial Key Laboratory of Infection and Immunology, Department of Immunology, School of Basic Medical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, 250012, Shandong, China について
Xiong Gaozhong について
Department of Pharmacology, School of Basic Medical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, 250012, Shandong, China について
Ma Dapeng について
Shandong Provincial Key Laboratory of Infection and Immunology, Department of Immunology, School of Basic Medical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, 250012, Shandong, China について
Lin Yueke について
Shandong Provincial Key Laboratory of Infection and Immunology, Department of Immunology, School of Basic Medical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, 250012, Shandong, China について
Lv Xiaoting について
Shandong Provincial Key Laboratory of Infection and Immunology, Department of Immunology, School of Basic Medical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, 250012, Shandong, China について
Zhao Yunxue について
Department of Pharmacology, School of Basic Medical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, 250012, Shandong, China について
Ma Xiaomin について
Shandong Provincial Key Laboratory of Infection and Immunology, Department of Immunology, School of Basic Medical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, 250012, Shandong, China について
Zhu Lihui について
Department of Gastroenterology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, 250021, Shandong, China について
Shen Xuecheng について
Shandong Provincial Key Laboratory of Infection and Immunology, Department of Immunology, School of Basic Medical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, 250012, Shandong, China について
Yang Min について
Shandong Provincial Key Laboratory of Infection and Immunology, Department of Immunology, School of Basic Medical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, 250012, Shandong, China について
Qin Zhenzhi について
Shandong Provincial Key Laboratory of Infection and Immunology, Department of Immunology, School of Basic Medical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, 250012, Shandong, China について
Cheng Yeping について
Shandong Provincial Key Laboratory of Infection and Immunology, Department of Immunology, School of Basic Medical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, 250012, Shandong, China について
Xuan Haocheng について
Shandong Provincial Key Laboratory of Infection and Immunology, Department of Immunology, School of Basic Medical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, 250012, Shandong, China について
Department of Infectious Diseases, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, 250021, Shandong, China について
Han Lihui について
Shandong Provincial Key Laboratory of Infection and Immunology, Department of Immunology, School of Basic Medical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, 250012, Shandong, China について
Han Lihui について
Shandong Provincial Clinical Research Center for Immune Diseases and Gout, Jinan, 250012, China について
Cancer Letters について
相互作用 について
抗腫瘍作用 について
死亡率 について
腫瘍 について
副作用 について
リン酸化 について
併用療法 について
ターゲティング について
肝細胞癌 について
治療計画 について
分子標的療法 について
チロシンリン酸化 について
残基 について
肝細胞癌 について
薬剤耐性 について
PARP1阻害剤 について
併用療法 について
腫瘍抵抗性 について
合成致死 について
細胞生理一般 について
腫ようの化学・生化学・病理学 について
SRC について
仲介 について
チロシンりん酸化 について
阻害 について
HCC について